These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4699516)

  • 1. The effect of sodium dextrothyroxine on serum cholesterol and mortality rates in cardiac patients.
    Bernstein A; Simon F; Schmitz TH; Warner WL
    Angiology; 1973 Apr; 24(4):205-11. PubMed ID: 4699516
    [No Abstract]   [Full Text] [Related]  

  • 2. The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.
    Stamler J
    Adv Exp Med Biol; 1977; 82():52-75. PubMed ID: 335823
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of dextrothyroxine on hyperlipidemia and experimental atherosclerosis in beagle dogs.
    Nandan R; Fisher JD; Towery EP; Brown DR; Ganote E; Jennings RB
    Atherosclerosis; 1975; 22(2):299-311. PubMed ID: 172095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextrothyroxine for lowering serum cholesterol. Analysis of data on 6066 patients.
    Bechtol LD; Warner WL
    Angiology; 1969 Nov; 20(10):565-79. PubMed ID: 5347944
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a hypocholesterolemic agent. Dextrothyroxine sodium (Choloxin).
    JAMA; 1969 May; 208(6):1014-5. PubMed ID: 5818672
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac tolerance for cholesteropenic doses of dextrothyroxine.
    Starr P
    J Clin Pharmacol J New Drugs; 1970; 10(6):400-7. PubMed ID: 5273962
    [No Abstract]   [Full Text] [Related]  

  • 8. Dextrothyroxine therapy for the disordered lipid metabolism of preclinical hypothyroidism.
    Calay R; Kocheleff P; Jonniaux G; Sohet L; Bastenie PA
    Lancet; 1971 Jan; 1(7692):205-6. PubMed ID: 4099873
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids.
    Best MM; Duncan CH
    Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616
    [No Abstract]   [Full Text] [Related]  

  • 10. Sodium dextrothyroxine as a hypocholesterolemic agent: retrospective analysis of 6000 patients.
    Williams W; Warner W
    Manit Med Rev; 1968 Oct; 48(8):374-6. PubMed ID: 5724155
    [No Abstract]   [Full Text] [Related]  

  • 11. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.
    JAMA; 1972 May; 220(7):996-1008. PubMed ID: 4337170
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of dyslipemias with the association of dx-thyroxine and choleretics].
    Martinelli M; Albini U; Villecco A
    Boll Soc Ital Cardiol; 1970; 15(6):539-43. PubMed ID: 5517650
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of erythritol-tetra-nicotinate on serum-cholesterol levels in man.
    Brox D; Selvaag O
    Acta Med Scand; 1967 Oct; 182(4):437-44. PubMed ID: 6054827
    [No Abstract]   [Full Text] [Related]  

  • 14. Dextrothyroxine treatment of phosphorylase-kinase deficiency glycogenosis in four boys.
    Garibaldi LR; Borrone C; de Martini I; Battistini E
    Helv Paediatr Acta; 1978 Nov; 33(4-5):435-41. PubMed ID: 280544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dextrothyroxine on the disappearance from the blood of C14-labeled cholesterol. A preliminary report.
    RABINOWITZ JL; RODMAN T; SMOLINSKY TL
    Angiology; 1962 Feb; 13():81-4. PubMed ID: 14489620
    [No Abstract]   [Full Text] [Related]  

  • 16. Why is low blood cholesterol associated with risk of nonatherosclerotic disease death?
    Jacobs DR
    Annu Rev Public Health; 1993; 14():95-114. PubMed ID: 8323608
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical use of dextrothyroxine in hypercholesterolemic states. An eight-year appraisal.
    Cohen BM
    J Clin Pharmacol J New Drugs; 1969; 9(1):45-56. PubMed ID: 5250312
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of dextrothyroxine on serum lipoprotein and cholesterol levels.
    Searcy RL; Hungerford DA; Low EM
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):177-86. PubMed ID: 4967872
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of D-thyroxine on fibrinolysis and on platelet adhesiveness and aggregation in arteriosclerotic subjects].
    Cajozzo A; Citarrella P; Abbadessa V; Di Marco P
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):984-90. PubMed ID: 4463990
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term changes of serum cholesterol with cholesterol-altering drugs in patients with coronary heart disease. Veterans Administration Drug-Lipid Cooperative Study.
    Detre KM; Shaw L
    Circulation; 1974 Nov; 50(5):998-1005. PubMed ID: 4609636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.